Cargando…
Crucial markers showing the risk of coronary artery disease in obesity: ADMA and neopterin
BACKGROUND: Obesity is responsible for high morbidity and mortality, both in developed and developing countries. It is associated with many chronic and metabolic diseases. Asymmetric dimethylarginine (ADMA) has been demonstrated to be a biomarker of endothelial dysfunction in humans and increased AD...
Autores principales: | Avci, Emre, Karabulut, Alpaslan, Alp, Avci Gulcin, Baba, Burcu, Bilgi, Cumhur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Medical Biochemists of Serbia, Belgrade
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710377/ https://www.ncbi.nlm.nih.gov/pubmed/33312061 http://dx.doi.org/10.5937/jomb0-24683 |
Ejemplares similares
-
Important Biomarkers that Play a Role in the Chronic Obstructive Pulmonary Disease Process
por: Avci, Emre, et al.
Publicado: (2018) -
Serum Neopterin Is Not Increased in Obese Juveniles
por: Mangge, Harald, et al.
Publicado: (2011) -
Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome
por: Agacayak, Elif, et al.
Publicado: (2015) -
ADMA in Vascular Disease: More than a Marker?
Publicado: (2005) -
The Relation Between Otolaryngology-Specific Symptoms and Computed Tomography Findings in Ambulatory Care COVID-19 Patients
por: Avcı, Hakan, et al.
Publicado: (2020)